Footwear that may help prevent falls in older adults who have fallen before
Official title: Evaluating the Impact of "CHUT OTONOM®" Footwear on the Spatio-temporal Parameters of Walking and the Risk of Falls in Elderly People at High Risk of Falling.
Run by University Hospital, Lille · NCT07366424 · Data updated 2026-11-12
This study tests whether wearing CHUT OTONOM footwear can improve walking patterns and reduce fall risk in seniors who have recently fallen.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 94 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 1 site (Lille) |
| Status | Recruiting |
| Started | February 3, 2026 |
| Main results expected | February 7, 2027 |
| Study ends | February 7, 2027 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07366424 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 65+ who have fallen recently, have feet that fit the available CHUT OTONOM sizes, can walk 10 meters without assistance, and are treated at Lille's Fall Assessment center with consent.
✕Probably not a fit
Patients unable to meet gait, consent, or size requirements, or with certain neurological or orthopedic deficits, may not benefit from the footwear intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates CHUT OTONOM shoes with a patented outsole designed to improve stability in older adults at risk for falls. Eligible participants are adults aged 65 and older who have fallen at least once in the past six months and can walk 10 meters unaided. The trial will observe changes in spatio-temporal walking parameters and assess potential reductions in fall risk while using the footwear. Recruitment is limited to patients seen at the Multidisciplinary Fall Assessment day hospital in Lille and who meet size availability and consent requirements. This is conducted under the leadership of Lille University Hospital with INNOTHERA Laboratories as collaborators.
Why it matters
Potential benefit: If successful, participants may experience improved balance and a lower likelihood of future falls while wearing the CHUT OTONOM shoes.
How similar studies have gone: Previous research has explored specialized footwear for balance, with mixed results depending on design and population; this trial tests a specific patented outsole in a well-defined older adult group.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, 65 years of age or older * Having fallen at least once in the previous 6 months. * Patients whose foot morphology corresponds to the sizes available in Innothera Laboratories' "CHUT OTONOM®" shoes (feet with increased volume). * Patients able to walk 10 meters unaided, without technical or human assistance. * Patients seen at the "Multidisciplinary Fall Assessment" day hospital at Calmette Hospital, Lille University Hospital. * Patients who have given their consent to participate in the study (written consent form signed). * Patients affiliated to a social health insurance scheme (beneficiaries or dependents). Exclusion Criteria: * Presence of a focal motor deficit in the lower limbs from neurological or orthopedic causes (e.g., hemiplegia resulting from a stroke, limb amputation, etc.). * Inability to give informed consent * Persons under legal protection (guardianship, curatorship, judicial protection)
Where it's running
-
CHU de Lille
Lille, France Recruiting
Study contacts
- Study coordinator: François PUISIEUX,, MD,PhD
- Email: francois.puisieux@chru-lille.fr
- Phone: 03.20.44.46.80
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pediatric Congenital Adrenal Hyperplasia: Long-Term Outcomes and Feelings of Regret
This study looks at adults who had classic CAH from 21-hydroxylase deficiency as children to see if early surgeries and management choices are linked to long‑term satisfaction or regret.
-
Predicting Low Cardiac Output in Children After Heart Surgery Using CO2-Derived Parameters
This study tests whether CO2-derived measures can help identify low cardiac output in children after congenital heart surgery.
-
Switching to Ofatumumab: IgG Levels in People with MS
A real-life study tests whether stopping ocrelizumab and starting ofatumumab changes IgG levels in adults with multiple sclerosis who have been on ocrelizumab for at least 18 months.
-
Identifying biomarkers for CAR-T cell therapy in cancer patients
This study looks at real-world CAR-T therapy in adults with blood cancers to see which biomarkers predict who responds or relapses.
-
Long-term real-world follow-up of adults with cutaneous squamous cell carcinoma needing systemic treatment in France
This study tests how adults with cutaneous squamous cell carcinoma who require systemic therapy are managed in real life, using a national French database across multiple centers.
-
Paravertebral Catheter Analgesia Versus Epidural Analgesia for Totally Minimally Invasive Esophagectomy
This trial tests whether paravertebral catheter analgesia can provide comparable pain control to epidural analgesia for patients undergoing totally minimally invasive esophagectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.